tirzepatide weight loss clinical trial New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Retatrutide vs. Tirzepatide: What's the

The fastest way to check yours is the state question in our booking section above and if were not in your state yet, you can leave your number and well call you the day we arrive

Food spends more time in your stomach, which can reduce the diversity and activity of certain beneficial bacteria species

Understanding how it differs from other therapies can help you and your doctor decide if its the right fit for your personalized wellness plan

If approved, your doctor will decide what dose of Wegovy to put you on based on your current Mounjaro dose

FDA labeling requires discarding any medication that has been frozen, regardless of appearance